Perceptive Xontogeny Venture Fund, LP - Insider Non-Derivative Transactions at Astria Therapeutics, Inc. (ATXS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 1, 2024, Perceptive Xontogeny Venture Fund, LP's relationship to Astria Therapeutics, Inc. (ATXS) is Director, and currently has 4,873,721 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ATXS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Perceptive Xontogeny Venture Fund, LP - Insider Non-Derivative Transactions of ATXS Common Stock

Perceptive Xontogeny Venture Fund, LP - Insider Non-Derivative Transactions at ATXS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 2, 2024	P -- (Common Stock)	2481350	12.09	4873721